Adenosine receptor agonist
An adenosine receptor agonist is a drug which acts as an agonist of one or more of the adenosine receptors. Examples include the neurotransmitter adenosine, its phosphates, adenosine monophosphate (AMP), adenosine diphosphate (ADP), and adenosine triphosphate (ATP), and the pharmaceutical drug regadenoson.
List of adenosine receptor agonists
- ATL146e (A2A selective)[1]
- PD81,723 (A1 allosteric enhancer)
- CF102 (Adenosine A3 receptor)[2]
References
- Glover, David K.; Riou, Laurent M.; Ruiz, Mirta; Sullivan, Gail W.; Linden, Joel; Rieger, Jayson M.; Macdonald, Timothy L.; Watson, Denny D.; Beller, George A. (April 2005). "Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A 2A receptor agonist, in reperfused canine myocardium". American Journal of Physiology. Heart and Circulatory Physiology. 288 (4): H1851–H1858. doi:10.1152/ajpheart.00362.2004.
- Cohen, S.; Stemmer, S.M.; Zozulya, G.; Ochaion, A.; Patoka, R.; Barer, F.; Bar-Yehuda, S.; Rath-Wolfson, L.; Jacobson, K.A.; Fishman, P. (September 2011). "CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver". Journal of Cellular Physiology. 226 (9): 2438–2447. doi:10.1002/jcp.22593. PMC 3474360.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.